# Evaluation of Fibrin Structure Marker in Cancer Patients Treated and Not Treated With LMWH

> **NCT02552381** · — · COMPLETED · sponsor: **Diagnostica Stago R&D** · enrollment: 389 (actual)

## Conditions studied

- Malignant Tumor

## Interventions

- **OTHER:** Fibrin Structure

## Key facts

- **NCT ID:** NCT02552381
- **Lead sponsor:** Diagnostica Stago R&D
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08
- **Primary completion:** 2019-12-20
- **Final completion:** 2019-12-20
- **Target enrollment:** 389 (ACTUAL)
- **Last updated:** 2020-01-07

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02552381

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02552381, "Evaluation of Fibrin Structure Marker in Cancer Patients Treated and Not Treated With LMWH". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02552381. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*